0001012975-16-001310.txt : 20160621 0001012975-16-001310.hdr.sgml : 20160621 20160621135439 ACCESSION NUMBER: 0001012975-16-001310 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 EFFECTIVENESS DATE: 20160621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centrexion Therapeutics Corp CENTRAL INDEX KEY: 0001592052 IRS NUMBER: 320402377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-265466 FILM NUMBER: 161724021 BUSINESS ADDRESS: STREET 1: 509 S. EXETER ST., SUITE 202 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 212-956-1111 MAIL ADDRESS: STREET 1: 509 S. EXETER ST., SUITE 202 CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: Centrexion Corp DATE OF NAME CHANGE: 20131114 D 1 primary_doc.xml X0707 D LIVE 0001592052 Centrexion Therapeutics Corp 509 S. EXETER ST., SUITE 202 BALTIMORE MD MARYLAND 21202 410-522-8701 DELAWARE Centrexion Corp Corporation true 2013 Sol Barer c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Isaac Blech c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Kerrie L. Brady c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer James N. Campbell c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer Director Jeffrey B. Kindler c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer Arnold L. Oronsky c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Gregg Beloff c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer Shengda Zan c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Biotechnology Decline to Disclose 06b false 2016-06-14 false true Convertible notes and associated warrants false 0 N/A None Maxim Group LLC 120708 405 Lexington Avenue New York NY NEW YORK 10174 All States false Indefinite 11163500 Indefinite The notes are convertible upon certain qualified financings at a price per share that is variable depending on the price per share paid in such financing. false 61 669810 0 0 true false Centrexion Therapeutics Corp /s/ Kerrie Brady Kerrie Brady Authorized Person 2016-06-21